Japan Opioids Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Opioids market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Opioids market. Detailed analysis of key players, along with key growth strategies adopted by Opioids industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Actavis Plc

    • Endo Pharmaceuticals Inc

    • Purdue Pharma

    • Janssen Pharmaceuticals

    • Sanofi

    • Egalet

    • Pfizer Inc

    • Boehringer Ingelheim

    • Sun Pharmaceutical Industries Ltd

    • Mallinckrodt Pharmaceuticals

    By Type:

    • Morphine

    • Codeine

    • Methadone

    • Meperidine

    • Fentanyl

    By End-User:

    • Anesthesia

    • Cough Suppressant

    • Diarrhea suppressant

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioids Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Opioids Market Size and Growth Rate of Morphine from 2014 to 2026

      • 1.3.2 Japan Opioids Market Size and Growth Rate of Codeine from 2014 to 2026

      • 1.3.3 Japan Opioids Market Size and Growth Rate of Methadone from 2014 to 2026

      • 1.3.4 Japan Opioids Market Size and Growth Rate of Meperidine from 2014 to 2026

      • 1.3.5 Japan Opioids Market Size and Growth Rate of Fentanyl from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Opioids Market Size and Growth Rate of Anesthesia from 2014 to 2026

      • 1.4.2 Japan Opioids Market Size and Growth Rate of Cough Suppressant from 2014 to 2026

      • 1.4.3 Japan Opioids Market Size and Growth Rate of Diarrhea suppressant from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioids Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioids by Major Types

      • 3.4.1 Market Size and Growth Rate of Morphine

      • 3.4.2 Market Size and Growth Rate of Codeine

      • 3.4.3 Market Size and Growth Rate of Methadone

      • 3.4.4 Market Size and Growth Rate of Meperidine

      • 3.4.5 Market Size and Growth Rate of Fentanyl

    4 Segmentation of Opioids Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioids by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioids in Anesthesia

      • 4.4.2 Market Size and Growth Rate of Opioids in Cough Suppressant

      • 4.4.3 Market Size and Growth Rate of Opioids in Diarrhea suppressant

    5 Market Analysis by Regions

    • 5.1 Japan Opioids Production Analysis by Regions

    • 5.2 Japan Opioids Consumption Analysis by Regions

    6 Hokkaido Opioids Landscape Analysis

    • 6.1 Hokkaido Opioids Landscape Analysis by Major Types

    • 6.2 Hokkaido Opioids Landscape Analysis by Major End-Users

    7 Tohoku Opioids Landscape Analysis

    • 7.1 Tohoku Opioids Landscape Analysis by Major Types

    • 7.2 Tohoku Opioids Landscape Analysis by Major End-Users

    8 Kanto Opioids Landscape Analysis

    • 8.1 Kanto Opioids Landscape Analysis by Major Types

    • 8.2 Kanto Opioids Landscape Analysis by Major End-Users

    9 Chubu Opioids Landscape Analysis

    • 9.1 Chubu Opioids Landscape Analysis by Major Types

    • 9.2 Chubu Opioids Landscape Analysis by Major End-Users

    10 Kinki Opioids Landscape Analysis

    • 10.1 Kinki Opioids Landscape Analysis by Major Types

    • 10.2 Kinki Opioids Landscape Analysis by Major End-Users

    11 Chugoku Opioids Landscape Analysis

    • 11.1 Chugoku Opioids Landscape Analysis by Major Types

    • 11.2 Chugoku Opioids Landscape Analysis by Major End-Users

    12 Shikoku Opioids Landscape Analysis

    • 12.1 Shikoku Opioids Landscape Analysis by Major Types

    • 12.2 Shikoku Opioids Landscape Analysis by Major End-Users

    13 Kyushu Opioids Landscape Analysis

    • 13.1 Kyushu Opioids Landscape Analysis by Major Types

    • 13.2 Kyushu Opioids Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Actavis Plc

      • 14.1.1 Actavis Plc Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Endo Pharmaceuticals Inc

      • 14.2.1 Endo Pharmaceuticals Inc Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Purdue Pharma

      • 14.3.1 Purdue Pharma Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Janssen Pharmaceuticals

      • 14.4.1 Janssen Pharmaceuticals Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Egalet

      • 14.6.1 Egalet Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Pfizer Inc

      • 14.7.1 Pfizer Inc Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Boehringer Ingelheim

      • 14.8.1 Boehringer Ingelheim Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Sun Pharmaceutical Industries Ltd

      • 14.9.1 Sun Pharmaceutical Industries Ltd Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Mallinckrodt Pharmaceuticals

      • 14.10.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 131 Figures and 169 Tables)

    • Figure Japan Opioids Market Size and Growth Rate of Morphine from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Codeine from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Methadone from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Meperidine from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Fentanyl from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Opioids Market Size and Growth Rate of Anesthesia from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Cough Suppressant from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Diarrhea suppressant from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Opioids Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioids Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioids

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioids by Different Types from 2014 to 2026

    • Table Consumption Share of Opioids by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Morphine

    • Figure Market Size and Growth Rate of Codeine

    • Figure Market Size and Growth Rate of Methadone

    • Figure Market Size and Growth Rate of Meperidine

    • Figure Market Size and Growth Rate of Fentanyl

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioids by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioids by Different End-Users from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Anesthesia from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Cough Suppressant from 2014 to 2026

    • Figure Japan Opioids Market Size and Growth Rate of Diarrhea suppressant from 2014 to 2026

    • Table Japan Opioids Production by Regions

    • Table Japan Opioids Production Share by Regions

    • Figure Japan Opioids Production Share by Regions in 2014

    • Figure Japan Opioids Production Share by Regions in 2018

    • Figure Japan Opioids Production Share by Regions in 2026

    • Table Japan Opioids Consumption by Regions

    • Table Japan Opioids Consumption Share by Regions

    • Figure Japan Opioids Consumption Share by Regions in 2014

    • Figure Japan Opioids Consumption Share by Regions in 2018

    • Figure Japan Opioids Consumption Share by Regions in 2026

    • Table Hokkaido Opioids Consumption by Types from 2014 to 2026

    • Table Hokkaido Opioids Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Opioids Consumption Share by Types in 2014

    • Figure Hokkaido Opioids Consumption Share by Types in 2018

    • Figure Hokkaido Opioids Consumption Share by Types in 2026

    • Table Hokkaido Opioids Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Opioids Consumption Share by End-Users in 2014

    • Figure Hokkaido Opioids Consumption Share by End-Users in 2018

    • Figure Hokkaido Opioids Consumption Share by End-Users in 2026

    • Table Tohoku Opioids Consumption by Types from 2014 to 2026

    • Table Tohoku Opioids Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Opioids Consumption Share by Types in 2014

    • Figure Tohoku Opioids Consumption Share by Types in 2018

    • Figure Tohoku Opioids Consumption Share by Types in 2026

    • Table Tohoku Opioids Consumption by End-Users from 2014 to 2026

    • Table Tohoku Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Opioids Consumption Share by End-Users in 2014

    • Figure Tohoku Opioids Consumption Share by End-Users in 2018

    • Figure Tohoku Opioids Consumption Share by End-Users in 2026

    • Table Kanto Opioids Consumption by Types from 2014 to 2026

    • Table Kanto Opioids Consumption Share by Types from 2014 to 2026

    • Figure Kanto Opioids Consumption Share by Types in 2014

    • Figure Kanto Opioids Consumption Share by Types in 2018

    • Figure Kanto Opioids Consumption Share by Types in 2026

    • Table Kanto Opioids Consumption by End-Users from 2014 to 2026

    • Table Kanto Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Opioids Consumption Share by End-Users in 2014

    • Figure Kanto Opioids Consumption Share by End-Users in 2018

    • Figure Kanto Opioids Consumption Share by End-Users in 2026

    • Table Chubu Opioids Consumption by Types from 2014 to 2026

    • Table Chubu Opioids Consumption Share by Types from 2014 to 2026

    • Figure Chubu Opioids Consumption Share by Types in 2014

    • Figure Chubu Opioids Consumption Share by Types in 2018

    • Figure Chubu Opioids Consumption Share by Types in 2026

    • Table Chubu Opioids Consumption by End-Users from 2014 to 2026

    • Table Chubu Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Opioids Consumption Share by End-Users in 2014

    • Figure Chubu Opioids Consumption Share by End-Users in 2018

    • Figure Chubu Opioids Consumption Share by End-Users in 2026

    • Table Kinki Opioids Consumption by Types from 2014 to 2026

    • Table Kinki Opioids Consumption Share by Types from 2014 to 2026

    • Figure Kinki Opioids Consumption Share by Types in 2014

    • Figure Kinki Opioids Consumption Share by Types in 2018

    • Figure Kinki Opioids Consumption Share by Types in 2026

    • Table Kinki Opioids Consumption by End-Users from 2014 to 2026

    • Table Kinki Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Opioids Consumption Share by End-Users in 2014

    • Figure Kinki Opioids Consumption Share by End-Users in 2018

    • Figure Kinki Opioids Consumption Share by End-Users in 2026

    • Table Chugoku Opioids Consumption by Types from 2014 to 2026

    • Table Chugoku Opioids Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Opioids Consumption Share by Types in 2014

    • Figure Chugoku Opioids Consumption Share by Types in 2018

    • Figure Chugoku Opioids Consumption Share by Types in 2026

    • Table Chugoku Opioids Consumption by End-Users from 2014 to 2026

    • Table Chugoku Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Opioids Consumption Share by End-Users in 2014

    • Figure Chugoku Opioids Consumption Share by End-Users in 2018

    • Figure Chugoku Opioids Consumption Share by End-Users in 2026

    • Table Shikoku Opioids Consumption by Types from 2014 to 2026

    • Table Shikoku Opioids Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Opioids Consumption Share by Types in 2014

    • Figure Shikoku Opioids Consumption Share by Types in 2018

    • Figure Shikoku Opioids Consumption Share by Types in 2026

    • Table Shikoku Opioids Consumption by End-Users from 2014 to 2026

    • Table Shikoku Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Opioids Consumption Share by End-Users in 2014

    • Figure Shikoku Opioids Consumption Share by End-Users in 2018

    • Figure Shikoku Opioids Consumption Share by End-Users in 2026

    • Table Kyushu Opioids Consumption by Types from 2014 to 2026

    • Table Kyushu Opioids Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Opioids Consumption Share by Types in 2014

    • Figure Kyushu Opioids Consumption Share by Types in 2018

    • Figure Kyushu Opioids Consumption Share by Types in 2026

    • Table Kyushu Opioids Consumption by End-Users from 2014 to 2026

    • Table Kyushu Opioids Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Opioids Consumption Share by End-Users in 2014

    • Figure Kyushu Opioids Consumption Share by End-Users in 2018

    • Figure Kyushu Opioids Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Actavis Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis Plc

    • Figure Sales and Growth Rate Analysis of Actavis Plc

    • Figure Revenue and Market Share Analysis of Actavis Plc

    • Table Product and Service Introduction of Actavis Plc

    • Table Company Profile and Development Status of Endo Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Endo Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Endo Pharmaceuticals Inc

    • Table Product and Service Introduction of Endo Pharmaceuticals Inc

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Janssen Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals

    • Table Product and Service Introduction of Janssen Pharmaceuticals

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Egalet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Egalet

    • Figure Sales and Growth Rate Analysis of Egalet

    • Figure Revenue and Market Share Analysis of Egalet

    • Table Product and Service Introduction of Egalet

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Sun Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Sun Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.